Enalaprilat Anhydrous: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Enalaprilat Anhydrous. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 9.1% |
| Dizziness | 4.3% |
| Fatigue | 2.6% |
| Pneumonia | 2.4% |
| Urinary tract infection | 2.4% |
| Chest pain | 2.1% |
| Abdominal pain | 2.1% |
| Angina pectoris | 1.8% |
| Myocardial infarction | 1.8% |
| Diarrhea | 1.7% |
| Nausea | 1.7% |
| Vertigo | 1.2% |
| Asthenia | 0.9% |
| Cough | 0.9% |
| Syncope | 0.9% |
| Vomiting | 0.9% |
| Bronchitis | 0.9% |
| Hypotension | 0.6% |
| Rash | 0.4% |
| Dyspnea | 0.4% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Source: FDA labeling via NIH DailyMed (set 71e9fff3…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.